Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,959 total articles
Immutep Limited announced positive interim Phase I clinical trial results for IMP761, a first-in-class LAG-3 agonist antibody targeting autoimmune diseases. The single ascending dose study demonstrated favorable safety, tolerability, and significant pharmacodynamic activity at 7 mg/kg in healthy volunteers. These findings support further clinical d…
Arvinas, Inc. announced its participation in the Michael J. Fox Foundation-supported LRRK2 Investigative Therapeutics Exchange (LITE) and Parkinson’s Precision Medicine Initiative (PPMI) programs. This collaboration aims to advance ARV-102, an investigational PROTAC drug targeting LRRK2 for treating Parkinson’s disease and related neurodegenerative…
Diginex Limited announced an expansion of its supply chain product suite with Risk-to-Remedy, an integrated solution for supply chain transparency and labor rights compliance, designed to help businesses comply with tightening global human rights regulations. The enhancement combines technology for risk assessment, worker engagement, and grievance …
IMUNON, Inc. announced a structured financing deal raising up to $10 million to fund enrollment in its pivotal Phase 3 OVATION 3 trial of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The financing combines preferred stock issuance and secured promissory notes with favorable terms intended to minimize dilution. Recent Phase 2 …
LanzaTech Global, Inc. announced the IPO of its joint venture, Beijing Shougang LanzaTech Technology Co., Ltd., on the Hong Kong Stock Exchange. The JV raised approximately $75 million, achieving a market capitalization of around $750 million. LanzaTech retained an 8.38% stake post-IPO. The listing demonstrates commercial viability of LanzaTech's c…
VCI Global Limited (NASDAQ: VCIG) provided a strategic business update highlighting its expanding institutional investor base, which includes prominent players in digital assets and blockchain technology. The company is actively pursuing growth opportunities across artificial intelligence infrastructure, digital assets, real-world assets, and capit…
Amneal Pharmaceuticals announced FDA approval of its romidepsin injection solution, a ready-to-use formulation that simplifies hospital and pharmacy preparation compared to the previously marketed lyophilized powder. The product’s Competitive Generic Therapy designation grants Amneal 180 days of market exclusivity, enhancing its differentiated inje…
NextCure, Inc. announced the availability of a replay for its virtual Key Opinion Leader event discussing the first clinical efficacy data from the Phase 1 dose escalation study of SIM0505, an investigational antibody-drug conjugate targeting Cadherin-6, for ovarian and uterine serous carcinoma cancers. The event featured experts from leading cance…
ChronoScale Corporation announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to accelerate the company's AI infrastructure platform growth and global compute solutions delivery. These leadership additions aim to strengthen innovation and scale operations to meet rising enterprise demand…
ARS Pharmaceuticals has announced a collaboration with former NFL star Drew Brees to raise awareness about severe food allergies and the importance of preparedness using neffy®, an FDA-approved needle-free epinephrine nasal spray. This partnership aims to educate patients and caregivers on prompt treatment of severe allergic reactions to prevent an…
Celularity Inc. and Fountain Life announce the availability of cenplacel-L, a placental-derived allogeneic cell therapy, for investigational use by licensed physicians in Florida under recently enacted state legislation. This new regulatory framework allows use of certain cell therapies without FDA approval, enabling physician-directed application …
Aya Gold & Silver Inc. released its 2025 Sustainability Report showcasing meaningful advancements in environmental management—such as reduced water and greenhouse gas intensities—robust social investments in local communities and employee training, and enhanced governance practices including ESG-linked executive incentives and increased female work…
Avalon GloboCare Corp., a NASDAQ-listed technology innovation company focused on consumer health and AI technology markets, appointed Sam Knipper as its new Chief Financial Officer effective June 1, 2026. Knipper brings extensive experience in financial reporting, SEC compliance, and strategic finance, particularly within emerging growth companies …
WW International, Inc. announces integration of its Weight Watchers Med+ program with Eli Lilly's digital healthcare platform, LillyDirect, to enhance nationwide patient access to GLP-1 prescription weight loss medications combined with behavioral and clinical support. This collaboration aims to provide a comprehensive and accessible approach to we…
IperionX Limited announced the Definitive Feasibility Study results for its 100%-owned Titan Critical Minerals Project in Tennessee. The DFS shows robust economics with an after-tax NPV8 of $813 million, a 39% IRR, and $1.9 billion in after-tax free cash flow over 14 years. The project will produce heavy rare earth concentrate, titanium minerals, a…
BIO-key International's Chairman and CEO will present at the RedChip Future Tech Investor Conference, highlighting the company's significant revenue growth and anticipated profitability in the first half of 2026. The company, a leader in biometric authentication and identity access management, expects 1H 2026 revenues to increase by 50% compared to…
Ming Shing Group Holdings Limited reported the resignation of CEO Han Yan and independent director Dongjie Lao for personal reasons, with no disagreements involved. Zhijun Pan has been appointed as interim CEO, and the company is searching for a permanent replacement. Additionally, Tianhang Zhao has been re-designated as chairman of the compensatio…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, completed the acquisition of a 54% interest in CliniQuantum Ltd., an Israeli company specializing in quantum simulation for clinical trial data analysis. The acquisition includes issuance of NeuroThera shares to CliniQuantum shareholders and potential earn-out payments contingent…
Plus Therapeutics announced that CNSide Diagnostics, its wholly owned subsidiary, has achieved College of American Pathologists (CAP) accreditation for its Houston-based clinical laboratory. This accreditation validates the laboratory's high standards and quality controls, strengthening its position to expand the commercial use of the CNSide® CSF A…
Rezolute, Inc., a late-stage biotech company focused on treatments for refractory hypoglycemia due to hyperinsulinism, announced four presentations at the 2026 Endocrine Society Annual Meeting. These include data from the Phase 3 sunRIZE study of their drug ersodetug, which previously failed to meet primary endpoints but showed consistent glycemic …
Biogen Inc. announced that the FDA has granted Breakthrough Therapy Designation to its investigational antisense oligonucleotide, salanersen, for treating spinal muscular atrophy (SMA). Supported by positive Phase 1b data showing motor function improvements and slowing neurodegeneration in children with SMA, salanersen offers potential high efficac…
Microchip Technology's Armenian office has received a U.S. Department of Commerce export license authorizing them to develop advanced FPGA technologies within Armenia. This approval strengthens Armenia's role in the global semiconductor supply chain and supports Microchip’s commitment to innovation through expanded global engineering collaboration.
Global-e Online Ltd., a leading global direct-to-consumer e-commerce platform, announced that its Board of Directors has authorized a new share repurchase program of up to $500 million. This follows completion of about 80% of their previous $200 million repurchase plan. The program aims to return capital to shareholders while supporting strategic i…
The Catalyst/Millburn Hedge Strategy Fund (MBXIX) has exceeded $10 billion in assets under management, signaling increasing investor demand for alternative investment strategies that offer diversification and resilience through both bull and bear markets. The fund employs a systematic long/short managed futures approach combined with strategic equi…
Plug Power Inc. announced its annual shareholder meeting webcast will take place on June 11, 2026, featuring a presentation by CEO Jose Luis Crespo on the company’s corporate overview and operations in the hydrogen economy. The webcast is accessible to shareholders and the public, highlighting Plug Power's progress in hydrogen solutions, electrolyz…
